IGFBP2 and central nervous system cancer: For example, IGFBP2 has anti-apoptotic effects in multiple types of solid cancer[7,12,13,23], binds to integrin α5 resulting in migration of Ewing’s sarcoma cells[6], and activates integrin β1 to induce glioma cell motility[20].